Companies: 10,795·Total market cap: $144.5T
Mesoblast Limited

Mesoblast Limited

MESONASDAQHealthcare● Active
$13.80
$-0.15(-1.08%)
Market Cap$1.8B
P/E Ratio—
52W High$21.5
52W Low$9.88
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Mesoblast Limited (MESO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001345099 · MESO · NASDAQ · as of Jun 8, 2026

Filing snapshot

576
Total Filings
6-K
Latest Form
2026-04-30
Most Recent
2010
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001345099 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-08-29
Fiscal Year End
Aug 29, 2025
Accession No.
0001345099-25-000067
Primary Document
meso-20250630.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001345099 · Accession 0001345099-25-000067

Latest Key Filings

6-KQuarterly Report
6-K
2026-04-30
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-30
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-17
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-15
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-08
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-08
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-08
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-08
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
3Initial Statement of Beneficial Ownership
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-03-23
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
Showing 1–15 of 574 filingsForm 4 / 144 hidden· 576 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001345099  |  Exchange: NASDAQ · Healthcare

Mesoblast Limited (NASDAQ: MESO) has submitted 576 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2010. As a Healthcare sector company with CIK 0001345099, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Mesoblast Limited's most comprehensive regulatory disclosure. The most recent Mesoblast Limited 10-K was filed on 2025-08-29 for fiscal year ending 2025. Historical MESO 10-K annual reports are available from 2005 through 2025.

Investors researching Mesoblast Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
IBRX SEC Filings →LQDA SEC Filings →COGT SEC Filings →EWTX SEC Filings →GPCR SEC Filings →GLPG SEC Filings →OCUL SEC Filings →QURE SEC Filings →
→ MESO Financials→ MESO Earnings→ MESO Insider Trades

Frequently Asked Questions

MESO SEC Filings · 8 questions

Mesoblast Limited (MESO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 576 filings and access original documents at no cost. Mesoblast Limited's CIK is 0001345099.

MESO SEC filingsMesoblast Limited SEC documentsfind MESO 10-K